Medication info
Averin M Tablets 2/500mg (Glymeperide, Metformin Hydrochloride)

Averin M Tablets 2/500mg (Glymeperide, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletGlimepiride›2mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets (10 tablets PT Px 3), 100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 201107229 · Approved 2011.09.27 · Insurance code 670605930

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used as a treatment to help control blood sugar in type 2 diabetes patients by using Glymeperide and Metformin together, complementing dietary and exercise therapy.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Precautions

This medication may cause severe lactic acidosis or hypoglycemia, so caution is advised, especially in cases of rapid decline in kidney function. If there are symptoms of dehydration or if taking medications that may affect kidney function, it is advisable to temporarily discontinue this medication and consult a physician. As there may be an increased risk of death associated with cardiovascular disease, the cardiovascular condition should be closely monitored while using this medication. It should not be administered to insulin-dependent diabetes patients, patients with acute metabolic acidosis, patients with severe liver or kidney dysfunction, pregnant women, and nursing mothers. Careful monitoring is necessary from the beginning of treatment in patients or conditions with a high risk of hypoglycemia, and caution should be taken with missed meals, excessive exercise, and alcohol consumption. Gastrointestinal symptoms (diarrhea, nausea, vomiting, etc.) may commonly occur, but they are mostly temporary and should be discussed with a physician if severe symptoms arise. Allergic reactions or hematological anomalies may occur, so any unusual symptoms should be reported to healthcare providers immediately. Regular testing of blood sugar and kidney function should be conducted to continuously monitor the effectiveness and safety of the medication, particularly in elderly patients or patients with diminished kidney function. Due to many drug interactions, it is essential to consult a physician or pharmacist when starting or stopping any new medications. It is advisable to avoid using this medication while pregnant or breastfeeding, and insulin therapy is recommended as a substitute when necessary. In cases of overdose, there is a risk of hypoglycemia or lactic acidosis, so immediate medical attention is required. Caution should be exercised as hypoglycemia or other side effects may impair attention during driving or machine operation. Special attention is needed for children and the elderly, and regular monitoring of kidney function and vitamin B12 levels should be performed.

Side effects

Acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, indigestion, constipation, abdominal pain, metallic taste, visual impairment, taste disturbance, erythema, itching, urticaria, rash, thrombocytopenia, leukopenia, hemolytic anemia, anemia, agranulocytosis, pancytopenia, vitamin B12 deficiency, peripheral neuropathy, increased liver enzymes, liver dysfunction, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency due to diarrhea, encephalopathy, hair loss, weight gain, headache due to hypoglycemia, severe hunger, fatigue, sleep disturbances, instability, aggression, concentration deficit, attention deficit, abnormal reactions, depression, confusion, speech disorders, aphasia, visual disturbances, tremors, paralysis, sensory disturbances, dizziness, inability to self-regulate, delirium, cerebral convulsions, loss of consciousness, coma, weak respiration, slow pulse, sweating, clammy skin, anxiety, rapid pulse, hypertension, palpitations, angina, deep vein thrombosis, cardiac arrest, rectal carcinoma, abdominal pain, abdominal distension, vomiting, indigestion, palpitations, dizziness, diarrhea, nausea, leg edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets (10 tablets PT Px 3), 100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.